choline has been researched along with Carcinoma, Ductal, Breast in 17 studies
Carcinoma, Ductal, Breast: An invasive (infiltrating) CARCINOMA of the mammary ductal system (MAMMARY GLANDS) in the human BREAST.
Excerpt | Relevance | Reference |
---|---|---|
"To determine whether measurements of total choline (tCho) by 1H spectroscopy could predict morphological or pathological complete response (pCR) of neoadjuvant treatment and whether breast cancer subgroups are related to prediction accuracy." | 7.88 | Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: The impact of immunohistochemical status. ( Chao, SL; Chintinne, M; Drisis, S; Flamen, P; Ignatiadis, M; Lemort, M; Metens, T, 2018) |
"To explore factors determining the detection of total choline (tCho) by in vivo MR spectroscopy (MRS) in locally advanced breast cancer and to evaluate the ability of in vivo tCho to predict treatment response after one cycle of neoadjuvant chemotherapy (NAC)." | 7.77 | In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response. ( Bathen, TF; Bofin, A; Gribbestad, IS; Heldahl, MG; Lundgren, S; Sitter, B; Vettukattil, R, 2011) |
"Choline (Cho) signal identification and quantification in (1)H MRS are used in breast cancer diagnosis." | 5.16 | Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant? ( Baltzer, PA; Camara, O; Dietzel, M; Gajda, M; Gussew, A; Kaiser, WA; Reichenbach, JR; Rzanny, R, 2012) |
"To determine whether measurements of total choline (tCho) by 1H spectroscopy could predict morphological or pathological complete response (pCR) of neoadjuvant treatment and whether breast cancer subgroups are related to prediction accuracy." | 3.88 | Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: The impact of immunohistochemical status. ( Chao, SL; Chintinne, M; Drisis, S; Flamen, P; Ignatiadis, M; Lemort, M; Metens, T, 2018) |
"To explore factors determining the detection of total choline (tCho) by in vivo MR spectroscopy (MRS) in locally advanced breast cancer and to evaluate the ability of in vivo tCho to predict treatment response after one cycle of neoadjuvant chemotherapy (NAC)." | 3.77 | In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response. ( Bathen, TF; Bofin, A; Gribbestad, IS; Heldahl, MG; Lundgren, S; Sitter, B; Vettukattil, R, 2011) |
"To assess the relationship between breast cancer subtypes and choline detection by using in vivo proton magnetic resonance (MR) spectroscopy and to assess the feasibility of proton MR spectroscopy in the study of axillary lymph node metastases." | 3.71 | Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases. ( Tse, GM; Yang, WT; Yeung, DK, 2002) |
"ER negative breast cancer had bigger tumors compared to ER positive cancer (3." | 1.35 | Estrogen receptor and breast MR imaging features: a correlation study. ( Baek, HM; Chen, JH; Nalcioglu, O; Su, MY, 2008) |
"Choline peak in vivo is a specific but not sensitive marker of malignancy." | 1.33 | Evaluation of spectral selected press sequence in breast lesion characterization. ( Bao, RX; Liu, PF; Lu, H; Sun, F, 2006) |
"Choline was observed in all 19 cancer patients, while it was not detected in all other benign diseases." | 1.32 | In vivo 1H-MRS evaluation of malignant and benign breast diseases. ( Chung, DS; Kim, JK; Kim, OD; Lee, HM; Lee, YH; Park, SH; Sung, NK, 2003) |
"To determine whether invasive breast cancer can be distinguished from benign lesions with proton magnetic resonance (MR) spectroscopy ex vivo on the basis of altered cellular chemistry." | 1.30 | Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy. ( Barraclough, BH; Barry, PA; Bilous, M; Doran, ST; Gillett, DJ; Lean, CL; Mackinnon, WB; Malycha, PL; Mountford, CE; Russell, P, 1997) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (11.76) | 18.2507 |
2000's | 8 (47.06) | 29.6817 |
2010's | 6 (35.29) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Sodano, C | 1 |
Clauser, P | 1 |
Dietzel, M | 2 |
Kapetas, P | 1 |
Pinker, K | 1 |
Helbich, TH | 1 |
Gussew, A | 2 |
Baltzer, PA | 2 |
Drisis, S | 1 |
Flamen, P | 1 |
Ignatiadis, M | 1 |
Metens, T | 1 |
Chao, SL | 1 |
Chintinne, M | 1 |
Lemort, M | 1 |
Suppiah, S | 1 |
Rahmat, K | 1 |
Mohd-Shah, MN | 1 |
Azlan, CA | 1 |
Tan, LK | 1 |
Aziz, YF | 1 |
Vijayananthan, A | 1 |
Wui, AL | 1 |
Yip, CH | 1 |
Mimmi, MC | 1 |
Finato, N | 1 |
Pizzolato, G | 1 |
Beltrami, CA | 1 |
Fogolari, F | 1 |
Corazza, A | 1 |
Esposito, G | 1 |
Sun, K | 1 |
Chai, W | 1 |
Fu, C | 1 |
Zhan, Y | 1 |
Shen, K | 1 |
Luo, X | 1 |
Yan, F | 1 |
Rzanny, R | 1 |
Gajda, M | 1 |
Camara, O | 1 |
Reichenbach, JR | 1 |
Kaiser, WA | 1 |
Bathen, TF | 1 |
Heldahl, MG | 1 |
Sitter, B | 1 |
Vettukattil, R | 1 |
Bofin, A | 1 |
Lundgren, S | 1 |
Gribbestad, IS | 1 |
Yeung, DK | 2 |
Yang, WT | 2 |
Tse, GM | 2 |
Kim, JK | 1 |
Park, SH | 1 |
Lee, HM | 1 |
Lee, YH | 1 |
Sung, NK | 1 |
Chung, DS | 1 |
Kim, OD | 1 |
King, AD | 1 |
Cheung, HS | 1 |
Lu, H | 1 |
Liu, PF | 1 |
Bao, RX | 1 |
Sun, F | 1 |
Baek, HM | 2 |
Chen, JH | 2 |
Nalcioglu, O | 2 |
Su, MY | 2 |
Mackinnon, WB | 1 |
Barry, PA | 1 |
Malycha, PL | 1 |
Gillett, DJ | 1 |
Russell, P | 1 |
Lean, CL | 1 |
Doran, ST | 1 |
Barraclough, BH | 1 |
Bilous, M | 1 |
Mountford, CE | 1 |
Malycha, P | 1 |
Mountford, C | 1 |
Jagannathan, NR | 1 |
Kumar, M | 1 |
Seenu, V | 1 |
Coshic, O | 1 |
Dwivedi, SN | 1 |
Julka, PK | 1 |
Srivastava, A | 1 |
Rath, GK | 1 |
Cecil, KM | 1 |
Schnall, MD | 1 |
Siegelman, ES | 1 |
Lenkinski, RE | 1 |
1 review available for choline and Carcinoma, Ductal, Breast
Article | Year |
---|---|
In vivo proton magnetic resonance spectroscopy of breast lesions: an update.
Topics: Breast; Breast Neoplasms; Carcinoma; Carcinoma, Ductal, Breast; Choline; Disease Progression; False | 2007 |
2 trials available for choline and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant?
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Contrast Media | 2012 |
Evaluation of total choline from in-vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer.
Topics: Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Choline; Combined | 2001 |
14 other studies available for choline and Carcinoma, Ductal, Breast
Article | Year |
---|---|
Clinical relevance of total choline (tCho) quantification in suspicious lesions on multiparametric breast MRI.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Diseases; Breast Neoplasms; Carcinoma, Ductal, Breast | 2020 |
Total choline quantification measured by 1H MR spectroscopy as early predictor of response after neoadjuvant treatment for locally advanced breast cancer: The impact of immunohistochemical status.
Topics: Adult; Analysis of Variance; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Female; Follow-Up | 2018 |
Improved diagnostic accuracy in differentiating malignant and benign lesions using single-voxel proton MRS of the breast at 3 T MRI.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Early | 2013 |
Absolute quantification of choline-related biomarkers in breast cancer biopsies by liquid chromatography electrospray ionization mass spectrometry.
Topics: Acetonitriles; Biomarkers, Tumor; Biopsy; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carci | 2013 |
Diffusion-Weighted Imaging-guided MR Spectroscopy in Breast Lesions using Readout-Segmented Echo-Planar Imaging.
Topics: Adult; Aged; Aged, 80 and over; Breast; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobu | 2016 |
In vivo MRS of locally advanced breast cancer: characteristics related to negative or positive choline detection and early monitoring of treatment response.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Female; Humans | 2011 |
Breast cancer: in vivo proton MR spectroscopy in the characterization of histopathologic subtypes and preliminary observations in axillary node metastases.
Topics: Adult; Aged; Aged, 80 and over; Axilla; Biopsy, Needle; Breast Neoplasms; Carcinoma, Ductal, Breast; | 2002 |
In vivo 1H-MRS evaluation of malignant and benign breast diseases.
Topics: Adolescent; Adult; Aged; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Diagnosis, Differenti | 2003 |
Evaluation of spectral selected press sequence in breast lesion characterization.
Topics: Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Female; Fibroa | 2006 |
Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Ca | 2008 |
Estrogen receptor and breast MR imaging features: a correlation study.
Topics: Adult; Aged; Axilla; Breast Neoplasms; Carcinoma, Ductal, Breast; Choline; Female; Humans; Lymphatic | 2008 |
Fine-needle biopsy specimens of benign breast lesions distinguished from invasive cancer ex vivo with proton MR spectroscopy.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Breast; Breast Neoplasms; Carcinoma in Situ; Carcino | 1997 |
Magnetic resonance spectroscopy and breast cancer.
Topics: Biopsy, Needle; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Choline; Creatine; F | 1998 |
The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, | 2001 |